Piotr Mateusz Mydel

Piotr Mateusz Mydel


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 June 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
MSMattias N. D. Svensson
Mattias N. D. Svensson
MZMartina Zoccheddu
Martina Zoccheddu
SYShen Yang
Shen Yang
GNGyrid Nygaard
Gyrid Nygaard
CSChristian Secchi
Christian Secchi
NBNunzio Bottini
Nunzio Bottini
PTPRS-targeted FLS-directed therapy synergizes with TNF inhibition in therapy of arthritis.

Verified
Journal Article
Open access
PDF file
AAArdita Aliko
Ardita Aliko
MKMarta Kamińska
Marta Kamińska
KFKatherine Falkowski
Katherine Falkowski
EBEwa Bielecka
Ewa Bielecka
MBMałgorzata Benedyk-Machaczka
Małgorzata Benedyk-Machaczka
PMPiotr Mateusz Mydel
Piotr Mateusz Mydel
Citrullination, a posttranslational modification, is catalyzed by peptidylarginine deiminases (PADs), a unique family of enzymes that converts peptidyl-arginine to peptidyl-citrulline. Overexpression and/or increased PAD activity is observed in rheumatoid arthritis (RA), Alzheimer’s disease, multiple sclerosis, and cancer. Moreover, bacterial PADs, such as Porphyromonas gingivalis PAD (PPAD), may have a role in the pathogenesis of RA, indicating PADs as promising therapeutic targets. Herein, six novel compounds were examined as potential inhibitors of human PAD4 and PPAD, and compared to an irreversible PAD inhibitor, Cl-amidine. Four of the tested compounds (compounds 2, 3, 4, and 6) exhibited a micromolar-range inhibition potency against PAD4 and no effect against PPAD in the in vitro assays. Compound 4 was able to inhibit the PAD4-induced citrullination of H3 histone with higher efficiency than Cl-amidine. In conclusion, compound 4 was highly effective and presents a promising direction in the search for novel RA treatment strategies.

20 September 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AAArdita Aliko
Ardita Aliko
MKMarta Kamińska
Marta Kamińska
BBBrith Bergum
Brith Bergum
KGKatarzyna Gawron
Katarzyna Gawron
MBMałgorzata Benedyk
Małgorzata Benedyk
PMPiotr Mateusz Mydel
Piotr Mateusz Mydel
Peptidylarginine deiminase (PPAD) is a virulence factor unique to pathogenic Porphyromonas species, especially P. gingivalis. Mechanistically, PPAD activity, in conjunction with Arg-specific gingipains, generates protein fragments with citrullinated C-termini. Such polypeptides are potential de novo epitopes that are key drivers of rheumatoid arthritis. This process could underlie the observed clinical association between rheumatoid arthritis and periodontitis. However, the role of PPAD in host colonization by P. gingivalis and, subsequently, in triggering periodontitis is not known. Therefore, the aim of the current study was to delineate the role of PPAD in bacterial biofilm formation, and to define whether adherence to, invasion of, and host responses to bacteria of gingival keratinocytes depend on PPAD activity. We studied these aspects using PPAD-competent and PPAD-incompetent strains of P. gingivalis, and demonstrated that neither biofilm formation nor its composition was affected by PPAD activity. Similarly, flow cytometry revealed that PPAD did not impact the ability of P. gingivalis to adhere to and, subsequently, invade keratinocytes. Network analyses of gene expression patterns, however, revealed a group of host genes that were sensitive to PPAD activity (CXCL8, IL36G, CCL20, and IL1B). These genes can be categorized as potent immune modulators belonging to the interleukin 1 system, or chemoattractants of lymphocytes and neutrophils. Thus, we conclude that PPAD, although it is a potent modulator of the immune response, does not affect bacterial biofilm formation or the ability of P. gingivalis to adhere to and invade gingival epithelial cells.

15 February 2016 in Innate Immunity
Verified
Journal Article
Open access
PDF file
CKCatalin Koro
Catalin Koro
AHAnnelie Hellvard
Annelie Hellvard
NDNicolas Delaleu
Nicolas Delaleu
VBVeronika Binder
Veronika Binder
CSCarsten Scavenius
Carsten Scavenius
PMPiotr Mateusz Mydel
Piotr Mateusz Mydel
Carbamylation of lysine residues and protein N-termini is an ubiquitous, non-enzymatic post-translational modification. Carbamylation at sites of inflammation is due to cyanate formation during the neutrophil oxidative burst and may target lysine residues within the antimicrobial peptide LL-37. The bactericidal and immunomodulatory properties of LL-37 depend on its secondary structure and cationic nature, which are conferred by arginine and lysine residues. Therefore, carbamylation may affect the biological functions of LL-37. The present study examined the kinetics and pattern of LL-37 carbamylation to investigate how this modification affects the bactericidal, cytotoxic and immunomodulatory function of the peptide. The results indicated that LL-37 undergoes rapid modification in the presence of physiological concentrations of cyanate, yielding a spectrum of diverse carbamylated peptides. Mass spectrometry analyses revealed that the N-terminal amino group of Leu-1 was highly reactive and was modified almost instantly by cyanate to generate the predominant form of the modified peptide, named LL-37C1. This was followed by the sequential carbamylation of Lys-8, Lys-12, and Lys-15 to yield LL-37C8, and Lys-15 to yield LL-37C12,15. Carbamylation had profound and diverse effects on the structure and biological properties of LL-37. In some cases, anti-inflammatory LL-37 was rapidly converted to pro-inflammatory LL-37.

13 August 2014 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
CKCatalin Koro
Catalin Koro
EBEwa Bielecka
Ewa Bielecka
ADAnders Dahl‐Knudsen
Anders Dahl‐Knudsen
JEJan J. Enghild
Jan J. Enghild
CSCarsten Scavenius
Carsten Scavenius
PMPiotr Mateusz Mydel
Piotr Mateusz Mydel
Post‐translational modifications of proteins significantly affect their structure and function. The carbamylation of positively charged lysine residues to form neutral homoitrulline occurs primarily under inflammatory conditions through myeloperoxidase‐dependent cyanate (CNO−) formation. We analyzed the pattern of human IgG1 carbamylation under inflammatory conditions and the effects that this modification has on the ability of antibodies to trigger complement activation via the classical pathway. We found that the lysine residues of IgG1 are rapidly modified after brief exposure to CNO−. Interestingly, modifications were not random, but instead limited to only few lysines within the hinge area and the N‐terminal fragment of the CH2 domain. A complement activation assay combined with mass spectrometry analysis revealed a highly significant inverse correlation between carbamylation of several key lysine residues within the hinge region and N‐terminus of the CH2 domain and the proper binding of C1q to human IgG1 followed by subsequent complement activation. This severely hindered complement‐dependent cytotoxicity of therapeutic IgG1. The reaction can apparently occur in vivo, as we found carbamylated antibodies in synovial fluid from rheumatoid arthritis patients. Taken together, our data suggest that carbamylation has a profound impact on the complement‐activating ability of IgG1 and reveals a pivotal role for previously uncharacterized lysine residues in this process.

2 December 2018 in Journal of Periodontology
Verified
Journal Article
Closed access
PDF file
MKMarta Kamińska
Marta Kamińska
AAArdita Aliko
Ardita Aliko
AHAnnelie Hellvard
Annelie Hellvard
EBEwa Bielecka
Ewa Bielecka
VBVeronika Binder
Veronika Binder
PMPiotr Mateusz Mydel
Piotr Mateusz Mydel